Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012768675
Mon, 13.11.2023
IGEA Pharma N.V.
IGEA announces annual General Meeting Resolutions
Hoofddorp, the Netherlands, 13 November 2023. IGEA Pharma N.V. (SIX: IGPH) announced the annual General Meeting Resolution.
Hoofddorp, the Netherlands, 13 November 2023. IGEA Pharma N.V. (SIX: IGPH) today announced that the Annual General Meeting approved all the agenda resolutions. The min [ … ]
Mon, 09.10.2023
IGEA Pharma N.V.
FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, AUSTRALIA, CANADA, OR JAPAN
IGEA to update on RBCARE business combination
Hoofddorp, the Nethe [ … ]
Tue, 03.10.2023
IGEA Pharma N.V.
FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, AUSTRALIA, CANADA, OR JAPAN
IGEA and RBCARE2023 signed to combine their businesses
Hoofddorp, [ … ]
Sat, 30.09.2023
IGEA Pharma N.V.
IGEA discloses its half-year figures 2023
Hoofddorp, the Netherlands, 30 September2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its unaudited interim financial statements as of 30 June 2023.
Overview
The Group discontinued in 2023 the industrial processing business as well as certain activities of the distribution segment [ … ]
Thu, 28.09.2023
IGEA Pharma N.V.
Convening notice
28 SEPTEMBER 2023
Dear Shareholder,
The board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) hereby invites you to attend the Annual General Meeting on 09.11.2023 (the “AGM”) that will take place at Tribes Amsterdam South Axis FOZ, Gustav Mahlerlaan 308, 1082 ME Amsterdam, the Netherlands. The meeting will start at [ … ]
Wed, 30.08.2023
IGEA Pharma N.V.
IGEA filed the appeal on SIX decision of delisting
Hoofddorp, the Netherlands, 30 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the filing of the appeal to the decision of the SIX to delist the company.
The board of directors, through his Lawyers, filed on August 28 its appeal to the decision of SIX to delist the company . As a [ … ]
Fri, 04.08.2023
IGEA Pharma N.V.
IGEA to update on SIX decision
Hoofddorp, the Netherlands, 4 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the intention to appeal the decision of the SIX to delist the company.
The new board of directors entered in charge by end of April 2023 acted immediately to grant continuation of the activities and to respect any publicati [ … ]
Mon, 31.07.2023
IGEA Pharma N.V.
IGEA discloses its Annual Report 2022
Hoofddorp, the Netherlands, 30 July 2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its Annual Report 2022.
Overview 2022
The Group did not start to generate revenue in the ‘Industrial processing’ segment as expected (same as previous period) and the ‘Distribution’ segment did not operat [ … ]
Mon, 31.07.2023
IGEA Pharma N.V.
IGEA discloses its Annual Report 2022
Hoofddorp, the Netherlands, 30 July 2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its Annual Report 2022.
Overview 2022
The Group did not start to generate revenue in the ‘Industrial processing’ segment as expected (same as previous period) and the ‘Distribution’ segment did not operat [ … ]
Wed, 31.05.2023
IGEA Pharma N.V.
IGEA to apply for a further extension of its disclosure obligations
Hoofddorp, the Netherlands, 31 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the submission of a further exemption application to the SIX.
The exemption application, dated 31 May 2023, requests an extension of the deadline to publish IGEA’s 2022 annual rep [ … ]